Endocrine disorders, other/unspecified

E4_ENDODISNAS

endocrine system disease: A disease involving the endocrine system.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E34.8, E34.9 Hospital discharge: ICD-9 — 2592 Hospital discharge: ICD-8 — 2589 Cause of death: ICD-10 — E34.8, E34.9 Cause of death: ICD-9 — 2592 Cause of death: ICD-8 — 2589 2 out of 7 registries used, show all original rules.	746
4. Check minimum number of events None	746
5. Include endpoints None	746
6. Filter based on genotype QC (FinnGen only)	746

Control definitions (FinnGen only)

Control exclude: E4_ENDOGLAND

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	E4_ENDODISNAS
CONTROL_EXCLUDE	E4_ENDOGLAND
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E34[8-9]
HD_ICD_9	2592
HD_ICD_8	2589
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E34[8-9]
COD_ICD_9	2592
COD_ICD_8	2589
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Endocrine disorders, other/unspecified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	4629	2915	1690
Only index persons	4059	2629	1430
Unadjusted period prevalence (%)
Whole population	0.07	0.08	0.05
Only index persons	0.08	0.10	0.05
Median age at first event (years)
Whole population	45.31	43.58	47.96
Only index persons	42.47	41.28	44.67

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	746	499	247
Unadjusted period prevalence (%)	0.15	0.17	0.11
Median age at first event (years)	43.89	40.67	50.39

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
703: Matched controls
7031

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

+∞

323.0

558

H02AB09

ATC

hydrocortisone; systemic

32.3

66.5

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

138.1

59.9

25898

ICD-8 Finland

Polyglandular dysfunction and other diseases of endocrine glands, Alii definiti

+∞

58.1

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

111.2

56.8

H03AA01

ATC

levothyroxine sodium; systemic

3.9

53.1

287

1062

25899

ICD-8 Finland

Polyglandular dysfunction and other diseases of endocrine glands, Other and unspecified diseases of endocrine system

+∞

48.5

XX3DW

NOMESCO Finland

Time consuming IT work

5.4

44.9

149

334

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

+∞

42.1

101

Kela drug reimbursment

Anterior pituitary hypofunction

+∞

40.0

E34.8

ICD-10 Finland

Other specified endocrine disorders

+∞

40.0

SPAT1262

SPAT

Handing over of treatment supplies

3.8

39.1

198

663

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

5.7

35.0

107

214

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

4.3

34.8

143

393

SPAT1312

SPAT

General health counselling

2.8

34.3

311

1551

SPAT1256

SPAT

Intramuscular and subcutaneous injection

2.7

34.2

362

1978

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

6.6

33.0

151

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

3.2

32.8

204

786

E23.00

ICD-10 Finland

Panhypopituitarism

+∞

32.5

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

7.5

32.5

119

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.6

31.2

353

1967

SPAT1249

SPAT

Treatment-related counselling outside office

2.5

28.1

345

1973

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

+∞

26.2

AA4CM

NOMESCO Finland

Extensive MRI examination of sella turcica with 3 Tesla magnet

270.1

25.9

H01CB02

ATC

octreotide; parenteral

140.2

25.8

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

5.8

25.5

142

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.6

25.3

243

1201

E34.0

ICD-10 Finland

Carcinoid syndrome

+∞

25.2

E22.1

ICD-10 Finland

Hyperprolactinaemia

258.8

24.8

WX723

NOMESCO Finland

CPAP therapy

7.0

24.2

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.5

24.1

250

1281

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

3.3

24.0

137

484

SPAT1263

SPAT

Sampling

2.3

23.9

355

2170

UJF32

NOMESCO Finland

Coloscopy

2.5

23.1

218

1055

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

+∞

23.0

106

Kela drug reimbursment

Hypoparathyroidism

+∞

23.0

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.4

22.7

254

1346

WX408

NOMESCO Finland

General anesthesy, balanced

2.5

22.4

232

1176

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

4.4

22.2

209

NH3EA

NOMESCO Finland

Feet X-ray examination with load

9.2

21.9

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

4.4

21.1

195

J01MA12

ATC

levofloxacin; systemic

2.7

20.3

155

656

SPAT1310

SPAT

Counselling related to known health issue

2.2

19.9

264

1496

105

Kela drug reimbursment

Adrenal cortical hypofunction

+∞

19.9

SPAT1377

SPAT

Polysomnography

5.8

19.2

101

104

Kela drug reimbursment

Thyroid insufficiency

3.8

18.4

242

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

18.2

18.4

JN3AD

NOMESCO Finland

Abdominal CT examination

3.7

18.0

241

-1

SPAT

5.6

17.9

101

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.4

17.9

304

A02BC01

ATC

omeprazole; systemic

2.2

17.6

220

1199

EP1AE

NOMESCO Finland

Neck ultrasound examination

4.6

17.6

144

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.3

17.5

315

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.8

17.2

125

512

A11CC03

ATC

alfacalcidol; systemic

8.4

17.0

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.1

16.8

353

G02CB01

ATC

bromocriptine; systemic

9.6

16.8

SPAT1153

SPAT

Removal of sutures

2.1

16.7

245

1424

H01AC01

ATC

somatropin; parenteral

+∞

16.7

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

5.6

16.7

-44

ICPC

Preventive immunization/medic

3.5

16.5

253

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.2

16.4

199

1061

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

6.1

16.1

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

21.6

16.1

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

16.0

277

1720

N06AA09

ATC

amitriptyline; systemic

3.1

15.8

337

G47.3

ICD-10 Finland

Sleep apnoea

2.3

15.8

167

835

SPAT1301

SPAT

No procedures

2.1

15.7

246

1461

E26.0

ICD-10 Finland

Primary hyperaldosteronism

+∞

15.7

E21.3

ICD-10 Finland

Hyperparathyroidism, unspecified

87.1

15.6

BCA31

NOMESCO Finland

Endoscopic unilateral adrenalectomy

87.1

15.6

JN7AQ

NOMESCO Finland

Somatostatin receptor SPET med low dose CT

163.5

15.5

SCA02

NOMESCO Finland

Analysis and advice of nutrition with regard to dentistry

3.1

15.4

324

XFE00

NOMESCO Finland

Epicardial ultrasonography

7.6

15.1

WX780

NOMESCO Finland

Remote monitoring CPAP

4.7

15.1

118

WX110

NOMESCO Finland

Local anesthesy

2.0

14.9

499

3903

H01CB03

ATC

lanreotide; parenteral

58.0

14.8

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.0

14.8

259

1600

A02BC02

ATC

pantoprazole; systemic

1.9

14.8

462

3518

WX402

NOMESCO Finland

General anaesthesia

2.4

14.8

141

668

D44.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Adrenal gland

11.7

14.4

A12AA04

ATC

calcium carbonate; oral

11.2

14.1

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

9.1

14.1

S02.51

ICD-10 Finland

Fracture of tooth, open

2.8

13.8

349

BCA30

NOMESCO Finland

Unilateral adrenalectomy

+∞

13.6

E22.0

ICD-10 Finland

Acromegaly and pituitary gigantism

+∞

13.6

XF404

NOMESCO Finland

Ambulatory ECG

3.0

13.5

292

UDC00

NOMESCO Finland

Ear microscopy

3.2

13.4

247

Z01.9

ICD-10 Finland

Special examination, unspecified

3.7

13.4

175

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

40.9

13.2

E21.0

ICD-10 Finland

Primary hyperparathyroidism

40.9

13.2

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.8

13.2

334

2328

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

6.0

13.2

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

5.1

13.1

205

Kela drug reimbursment

Chronic hypertension

2.1

13.1

179

996

WX400

NOMESCO Finland

Inhalation anesthesy

3.9

12.7

145

C03CA01

ATC

furosemide; systemic

2.0

12.7

178

998

121

Kela drug reimbursment

Severe hypofunction of sexual glands

6.8

12.6

A03FA01

ATC

metoclopramide; systemic, rectal

2.1

12.6

159

851

2592A

ICD-9 Finland

Other endocrine disorders, Carcinoid syndrome

+∞

12.5

A12AA06

ATC

calcium lactate gluconate; oral

+∞

12.5

D44.8

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement

+∞

12.5

8240/3-C17.9

ICD-O-3

Neuroendocrine tumor, NOS, of small intestine, NOS

+∞

12.5

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

+∞

12.5

E83.50

ICD-10 Finland

Hypercalcemia

14.7

12.3

SPAT1324

SPAT

Screening procedure

0.3

12.2

837

H02AB06

ATC

prednisolone; systemic

1.8

12.1

327

2304

N02AX02

ATC

tramadol; systemic, rectal

1.8

12.1

291

1976

HAHOM

NOMESCO Finland

7.4

12.1

-50

ICPC

Medication/prescr/renewal

4.0

12.1

126

A06AC01

ATC

ispaghula (psylla seeds); oral

2.0

11.9

176

1003

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.2

11.9

137

702

E0000UV

ATC

1.8

11.9

293

2004

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.9

11.8

286

SPAT1211

SPAT

Application of soft bandage

2.8

11.8

304

J01DB01

ATC

cefalexin; oral

2.0

11.7

576

4902

JN7AN

NOMESCO Finland

Somatostatin receptor isotope imaging

+∞

11.5

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

121.9

11.5

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

121.9

11.5

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

4.6

11.4

T90

ICPC

Diabetes non-insulin dependent

2.1

11.4

151

823

N06AX16

ATC

venlafaxine; oral

2.3

11.4

119

583

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

9.1

11.3

UKC02

NOMESCO Finland

Cystoscopy

2.4

11.3

103

473

N04BC06

ATC

cabergoline; oral (dopamine agonists)

35.7

11.3

JN4AD

NOMESCO Finland

Body CT examination

3.0

11.1

231

R50.9

ICD-10 Finland

Fever, unspecified

2.3

11.1

107

505

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.2

11.0

102

Z56.5

ICD-10 Finland

Uncongenial work

44.0

10.9

N05BA04

ATC

oxazepam; oral

1.9

10.9

183

1092

Z31.5

ICD-10 Finland

Genetic counselling

3.4

10.8

161

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

28.5

10.8

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

7.7

10.7

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.2

10.7

122

623

N02AA05

ATC

oxycodone; systemic

2.4

10.6

439

AA1AD

NOMESCO Finland

CT of head and brain

2.0

10.6

159

907

SPAT1260

SPAT

Consultation of another employee

2.1

10.4

137

741

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.7

10.4

284

T99

ICPC

Endocr/metab/nutrit disease other

8.4

10.4

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.1

10.3

121

624

C07AB02

ATC

metoprolol; systemic

2.1

10.3

134

723

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

3.8

10.2

120

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.0

10.2

144

802

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.2

10.2

105

512

N02BE01

ATC

paracetamol; systemic, rectal

2.0

10.2

596

5205

N05AH04

ATC

quetiapine; oral

2.1

10.1

127

673

SPAT1281

SPAT

Other administrative function

2.7

10.1

276

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.9

10.1

189

1164

C03DA01

ATC

spironolactone; oral

2.6

10.1

303

E66.01

ICD-10 Finland

Obesity due to excess calories

2.6

10.1

314

YHMAS

NOMESCO Finland

9.3

10.1

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

10.2

10.1

H02AA02

ATC

fludrocortisone; oral

14.8

10.0

R68.8

ICD-10 Finland

Other specified general symptoms and signs

12.4

9.9

R5140

NOMESCO Finland

Monitoring the use of the aid

2.5

9.8

353

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.5

9.8

333

R01AD12

ATC

fluticasone furoate; nasal

1.8

9.7

225

1483

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

13.6

9.7

C07AB07

ATC

bisoprolol; oral

1.7

9.7

288

2046

C17.2

ICD-10 Finland

Malignant neoplasm: Ileum

55.8

9.7

N06AX21

ATC

duloxetine; oral

2.3

9.6

418

K02

ICD-10 Finland

Dental caries

2.8

9.6

239

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

5.5

9.4

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

101.4

9.4

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

101.4

9.4

J01FF01

ATC

clindamycin; systemic

1.8

9.4

197

1258

H05BX01

ATC

cinacalcet; oral

+∞

9.4

E23.6

ICD-10 Finland

Other disorders of pituitary gland

+∞

9.4

WX610

NOMESCO Finland

Patient controlled analgesia

12.6

9.4

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

9.4

145

832

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

8.8

9.3

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

3.7

9.3

109

HMAK

NOMESCO Finland

2.2

9.2

477

H03BB01

ATC

carbimazole; oral

3.4

9.2

131

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

9.1

283

2027

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

9.1

349

2646

SPAT1254

SPAT

Administration of medicine

2.2

9.1

100

501

-54

ICPC

Repair/fix-suture/cast/prosth device

5.0

9.1

OAB72

NOMESCO Finland

Weight control and weight loss guidance

10.2

9.1

Y0099

ICD-8 Finland

Investigation of endocrine system and metabolism

15.8

9.1

SPAT1097

SPAT

Recording of ECG

2.1

9.1

102

517

T82

ICPC

Obesity

3.5

9.1

122

SAA04

NOMESCO Finland

Special inverstigation of mouth

3.0

9.0

184

A02BA02

ATC

ranitidine; systemic

1.9

9.0

139

799

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.2

9.0

469

A02BC05

ATC

esomeprazole; systemic

1.7

8.9

276

1974

ED1AA

NOMESCO Finland

Mandipular X-ray examination

12.7

8.9

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.9

8.9

148

875

130

Kela drug reimbursment

Malignant tumour

2.7

8.8

229

M79.6

ICD-10 Finland

Pain in limb

1.7

8.8

243

1680

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.4

8.7

315

E03

ICD-10 Finland

Other hypothyroidism

2.8

8.7

206

ZX070

NOMESCO Finland

Intensity modified radiotherapy

6.7

8.7

321

Kela drug reimbursment

Paricalcitol and cinacalcet

50.6

8.7

SPAT1094

SPAT

Continuous Positive Airway Pressure

7.8

8.7

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

8.7

221

1491

R51

ICD-10 Finland

Headache

3.2

8.7

149

B03BA03

ATC

hydroxocobalamin; parenteral

3.1

8.6

161

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.2

8.6

427

N06AB04

ATC

citalopram; systemic

1.8

8.6

160

979

R55

ICD-10 Finland

Syncope and collapse

2.3

8.6

345

R06.0

ICD-10 Finland

Dyspnoea

1.8

8.5

168

1049

WZC30

NOMESCO Finland

Teaching

2.1

8.4

494

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.7

8.4

A04AA02

ATC

granisetron; systemic, transdermal

2.9

8.4

176

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

2.6

8.4

243

318

Kela drug reimbursment

Teriparatide

+∞

8.3

E27.5

ICD-10 Finland

Adrenomedullary hyperfunction

+∞

8.3

E21.2

ICD-10 Finland

Other hyperparathyroidism

+∞

8.3

102

Kela drug reimbursment

Diabetes insipidus

+∞

8.3

E34.39

ICD-10 Finland

Short stature, not elsewhere classified

+∞

8.3

BB1BQ

NOMESCO Finland

Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT

+∞

8.3

TPH07

NOMESCO Finland

Cathetrisation of artery

2.4

8.3

313

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

10.9

8.3

R4180

NOMESCO Finland

Podiatric therapy

9.6

8.3

WZA10

NOMESCO Finland

Long statement of health and health related matters

7.2

8.3

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

7.2

8.3

N06AX11

ATC

mirtazapine; oral

1.7

8.3

212

1431

N03AX16

ATC

pregabalin; oral

1.8

8.2

157

965

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

3.4

8.2

121

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.7

8.2

213

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

8.2

124

706

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

8.2

152

929

X59

ICD-10 Finland

Exposure to unspecified factor

1.9

8.2

129

745

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

6.9

8.1

D82

ICPC

Teeth/gum disease

1.6

8.0

248

1759

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

4.5

8.0

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

8.0

160

1001

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.1

8.0

513

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

3.8

7.9

ZXA00

NOMESCO Finland

Right side

0.5

7.9

1144

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.1

7.9

457

C08CA01

ATC

amlodipine; oral

1.7

7.9

205

1384

JN4CD

NOMESCO Finland

Very extensive body CT

3.6

7.8

C10AC01

ATC

colestyramine; oral

4.0

7.7

SCA03

NOMESCO Finland

Preventive oral health care, extensive

3.1

7.6

134

R53

ICD-10 Finland

Malaise and fatigue

1.8

7.6

138

835

SPAT1238

SPAT

Brief therapy

4.4

7.6

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

7.5

173

1125

A11CC02

ATC

dihydrotachysterol; oral

80.9

7.4

E21.1

ICD-10 Finland

Secondary hyperparathyroidism, not elsewhere classified

80.9

7.4

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

80.9

7.4

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

5.7

7.4

L68.0

ICD-10 Finland

Hirsutism

13.5

7.4

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.4

7.4

281

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.0

7.4

501

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

4.1

7.3

R06AE07

ATC

cetirizine; oral

1.6

7.3

302

2286

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.1

7.3

392

103

Kela drug reimbursment

Diabetes, insulin-treated

1.7

7.3

158

1007

BB1AN

NOMESCO Finland

Parathyroid gland isotope imaging, 1 isotope

+∞

7.3

E22.9

ICD-10 Finland

Hyperfunction of pituitary gland, unspecified

+∞

7.3

E21.5

ICD-10 Finland

Disorder of parathyroid gland, unspecified

+∞

7.3

7834C

ICD-9 Finland

Symptoms concerning nutrition, metabolism and development, Lack of expected normal physiological development[HÄIRIINTYNYT PITUUSKASVU]

+∞

7.3

E24.0

ICD-10 Finland

Pituitary-dependent Cushing disease

+∞

7.3

N03AE01

ATC

clonazepam; systemic

2.8

7.3

172

WX302

NOMESCO Finland

Thoracal epidural anesthesy

3.0

7.3

133

SPAT1240

SPAT

Therapeutic discussion

2.1

7.3

422

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

5.5

7.3

E29.1

ICD-10 Finland

Testicular hypofunction

15.9

7.2

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

7.4

7.2

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.9

7.2

151

WX204

NOMESCO Finland

Axillary plexus blockaced

3.6

7.2

G02CB03

ATC

cabergoline; oral (prolactine inhibitors)

30.3

7.2

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

3.2

7.2

112

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.4

7.1

259

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

3.7

7.1

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

7.1

7.0

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.5

7.0

A10BK03

ATC

empagliflozin; oral

2.6

7.0

204

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

6.4

7.0

BAA60

NOMESCO Finland

Total thyroidectomy

4.5

6.9

N06AX12

ATC

bupropion; oral

2.5

6.9

219

R83

ICPC

Respiratory infection other

0.5

6.8

1171

S02.5

ICD-10 Finland

Fracture of tooth

3.8

6.8

E87.6

ICD-10 Finland

Hypokalaemia

3.9

6.8

ZXC50

NOMESCO Finland

Cryotherapy

4.6

6.8

SPAT1325

SPAT

Vaccination

1.6

6.8

213

1504

E83.51

ICD-10 Finland

Hypocalcemia

16.9

6.8

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.4

6.7

247

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

5.0

6.7

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

22.8

6.7

S18

ICPC

Laceration/cut

1.5

6.7

261

1942

XKD00

NOMESCO Finland

Uroflowmetry

2.0

6.6

410

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.3

6.6

262

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

3.0

6.6

125

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

4.4

6.6

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.8

6.6

113

672

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

4.2

6.6

GD2SN

NOMESCO Finland

Lung ventilation SPECT

10.1

6.6

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

6.9

6.5

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.1

6.5

115

XX7JT

NOMESCO Finland

Somatostatin isotope ablative therapy

70.5

6.4

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.7

6.4

155

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

6.4

113

674

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

6.6

6.4

N06AX18

ATC

reboxetine; oral

6.6

6.4

SPAT1341

SPAT

Referral to physician or dentist

8.3

6.4

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.3

6.3

242

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

6.0

6.3

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

6.3

365

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

4.6

6.3

U04

ICPC

Incontinence urine

3.0

6.3

112

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

18.2

6.3

NA3CM

NOMESCO Finland

Lumbar spine extensive MRI examination with 3 Tesla magnet

18.2

6.3

B81

ICPC

Anaemia vit B12/folate deficiency

3.2

6.3

101

A09AA02

ATC

multienzymes (lipase, protease etc.)

4.9

6.3

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

4.9

6.3

BBA70

NOMESCO Finland

Implantation or transplantation of parathyroid gland

+∞

6.3

2520A

ICD-9 Finland

Disorders of parathyroid gland, Hyperparathyroidism

+∞

6.3

E26.9

ICD-10 Finland

Hyperaldosteronism, unspecified

+∞

6.3

H05AA02

ATC

teriparatide; parenteral

+∞

6.3

C74.0

ICD-10 Finland

Malignant neoplasm: Cortex of adrenal gland

+∞

6.3

E20.8

ICD-10 Finland

Other hypoparathyroidism

+∞

6.3

E27.2

ICD-10 Finland

Addisonian crisis

+∞

6.3

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

7.1

6.2

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

26.9

6.2

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

26.9

6.2

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

6.2

118

720

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

2.7

6.2

160

B01AB10

ATC

tinzaparin; parenteral

2.3

6.2

248

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

6.2

527

J45.1

ICD-10 Finland

Nonallergic asthma

2.4

6.2

225

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

6.2

496

N03AX12

ATC

gabapentin; oral

1.8

6.2

101

586

G44.2

ICD-10 Finland

Tension-type headache

1.9

6.1

519

N03AX09

ATC

lamotrigine; oral

2.7

6.1

155

NAG65

NOMESCO Finland

Anterior and posterior fusion of lumbar spine

12.7

6.1

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

4.0

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(40761536) Microorganisms panel - Urine sediment

372

533

12.93

274.62

4.4

3.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

333

462

12.21

249.45

5.9

3.1

mmol/l

1.2

0.24

298

390

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

326

578

9.24

194.95

4.1

3.0

—

(3010421) pH of Blood

149

137

13.34

144.35

3.9

2.5

7.4

0.32

136

109

(3012501) Base excess in Blood by calculation

137

111

14.89

143.37

3.9

2.5

mmol/l

2.5

0.02

106

(3036481) Cortisol [Moles/volume] in Serum or Plasma

254

524

6.83

126.11

2.9

1.8

nmol/l

313.9

370.3

2.78

239

481

(1616796) Gas panel - Central venous blood

126

111

13.46

124.85

3.4

2.6

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

123

119

12.18

114.45

3.4

57.7

57.6

0.02

123

119

(3029937) Albumin [Presence] in Urine by Test strip

425

1647

4.67

96.01

4.2

3.7

estimate

0.0

0.17

296

568

(3041096) Erythrocytes [Presence] in Urine by Automated

435

1728

4.64

94.75

4.1

3.0

—

(3025159) Blasts/100 leukocytes in Blood

205

448

5.93

93.50

3.9

4.6

0.0

0.9

0.59

113

(3002179) Metamyelocytes/100 leukocytes in Blood

207

460

5.84

92.64

3.9

4.2

0.6

0.4

0.31

108

(40767503) Oxygen content in Capillary blood by calculation

104

108

11.03

91.66

2.9

2.2

17.2

15.8

1.35

(3021589) Normoblasts [#/volume] in Blood

559

2725

5.19

91.55

20.3

8.8

e9/l

0.0

0.44

530

2259

(3021440) Promyelocytes/100 leukocytes in Blood

207

477

5.62

88.68

3.9

4.5

0.1

0.2

0.41

139

(3017181) Myelocytes/100 leukocytes in Blood

210

506

5.38

85.24

3.8

4.4

0.7

0.9

0.42

154

(3021387) Prolactin [Units/volume] in Serum or Plasma

135

220

7.27

82.23

3.3

1.3

mu/l

337.8

304.2

0.55

116

196

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

11.62

82.22

3.6

2.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

371

1458

4.07

78.48

5.7

4.5

—

(3018418) pH of Serum or Plasma

394

1676

3.86

72.92

6.3

3.5

7.4

0.44

299

314

(3026782) Osmolality of Urine

295

1107

3.75

64.40

3.0

2.5

mosm/kgh2o

474.4

544.9

6.01

268

943

(1761868) Lipid panel - Serum or Plasma

462

2350

3.54

61.56

3.8

2.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

459

2400

3.37

56.93

4.1

3.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

297

1204

3.44

56.18

2.4

1.7

pmol/l

28889368.1

11122483.7

0.26

225

1016

(3035637) Corticotropin [Mass/volume] in Plasma

12.83

55.39

2.0

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

146

386

4.46

51.11

4.1

3.4

pmol/l

4.3

4.6

1.95

126

342

(3009214) Lutropin [Units/volume] in Serum or Plasma

150

6.52

50.60

1.5

1.3

u/l

11.5

9.1

0.61

121

(3000850) Epithelial cells [#/volume] in Urine

281

1172

3.24

49.67

3.0

2.3

e6/l

5.9

6.5

0.21

253

1032

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

10.54

49.50

2.4

1.7

31.6

31.9

0.11

(3032080) INR in Blood by Coagulation assay

413

2211

2.94

45.80

15.9

7.7

inr

1.2

0.26

341

660

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

162

5.72

42.39

2.1

1.4

—

(3013512) EKG study

334

1647

2.86

42.39

4.0

3.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

19.62

40.69

2.2

1.4

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

437

2513

2.78

40.63

7.6

5.2

mmol/l

1.2

2.56

394

2274

(3035350) Ketones [Presence] in Urine by Test strip

492

3064

2.78

38.12

4.2

3.4

estimate

0.0

0.00

313

574

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

9.05

37.36

2.0

1.2

nmol/l

—

(3021601) Nitrite [Presence] in Urine by Test strip

491

3081

2.74

37.00

4.7

4.6

estimate

0.0

0.50

313

583

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

8.63

36.71

2.1

1.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

8.39

36.61

2.1

1.2

nmol/l

0.6

0.5

1.24

(42870588) Differential panel, method unspecified - Blood

358

1950

2.61

35.75

7.1

5.9

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

381

2159

2.56

34.72

4.7

3.3

ng/l

34.9

54.6

0.49

281

1375

(3009261) Glucose [Presence] in Urine by Test strip

488

3113

2.64

34.54

4.2

3.4

estimate

0.0

0.50

303

563

(3015377) Calcium [Moles/volume] in Serum or Plasma

353

1954

2.53

33.48

3.5

3.3

mmol/l

2.3

1.01

338

1724

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

445

2785

2.48

31.71

8.1

6.0

mmol/l

1.2

0.37

172

2351

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

12.89

31.68

1.4

1.5

—

(3030467) Casts [#/volume] in Urine by Automated count

298

1556

2.52

31.62

3.4

2.8

e6/l

0.4

0.5

0.43

260

1152

(3002582) Erythrocytes [#/volume] in Urine

315

1699

2.48

31.03

3.5

2.9

e6/l

128.0

111.5

0.08

273

1284

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

12.40

30.92

1.4

1.5

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

204

895

2.76

30.79

4.2

3.1

mmol/l

0.8

0.07

191

847

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

9.65

30.25

1.4

1.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

168

676

2.92

29.75

6.3

5.3

mmol/l

1.0

1.1

1.94

159

632

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

7.75

29.53

1.4

1.2

pmol/l

264.2

326.9

0.51

(36304419) Bacteria [Presence] in Urine

290

1537

2.45

29.33

3.4

2.8

—

(3022145) Colonoscopy Study observation

164

666

2.87

28.45

1.4

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

10.39

27.54

1.4

1.5

—

(3021901) Oxygen saturation in Capillary blood

5.75

27.31

3.2

2.5

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

53.78

26.40

1.9

1.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

7.16

25.68

1.5

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

630

4863

2.90

25.63

7.6

4.0

pmol/l

15.6

14.6

13.74

568

4428

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

169

736

2.68

25.39

2.8

2.3

22.6

22.9

0.11

144

629

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

393

2485

2.23

25.20

3.5

2.2

nmol/l

78.7

76.4

0.87

363

2237

(3023323) Follitropin [Units/volume] in Serum or Plasma

325

3.32

23.95

1.7

1.3

iu/l

21.6

26.6

0.72

282

(3028626) Oxygen [Partial pressure] in Capillary blood

127

4.69

23.29

3.2

2.9

kpa

8.5

8.1

1.33

118

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

309

1821

2.19

23.09

3.4

2.5

u/l

55.1

56.1

0.13

266

1680

(3013826) Glucose [Moles/volume] in Serum or Plasma

478

3381

2.15

21.72

6.4

4.4

mmol/l

6.8

6.6

0.71

457

3145

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

153

4.18

21.49

5.1

3.2

mg/l

1.8

1.5

1.47

140

(3044889) 12 lead EKG panel

557

4194

2.29

21.48

5.3

3.6

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

446

3082

2.11

21.43

7.1

6.0

umol/l

10.5

10.7

0.09

418

2918

(3022948) Iron [Moles/volume] in Serum or Plasma

179

866

2.40

21.17

2.8

2.3

umol/l

12.9

13.3

0.28

155

794

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

279

1630

2.14

20.84

1.8

1.6

mmol/l

1.6

1.4

1.88

145

1393

(3004789) Transferrin [Mass/volume] in Serum or Plasma

168

796

2.43

20.78

2.8

2.3

g/l

2.4

0.06

145

734

(3042631) Mycobacterium sp identified in Specimen

5.58

20.63

2.2

2.6

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

328

2048

2.07

20.43

3.6

2.9

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

5.58

20.15

1.5

—

(3002385) Erythrocyte distribution width [Ratio]

647

5273

2.71

19.76

22.5

15.4

13.8

13.6

3.34

633

5170

(3017446) Testosterone [Moles/volume] in Serum or Plasma

358

2.96

19.65

4.1

2.0

nmol/l

12.4

13.4

0.45

326

(3025941) Bacteria identified in Stool by Culture

343

2.99

19.43

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

110

440

2.76

19.19

3.5

2.7

g/l

9.5

10.7

2.49

405

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

100

4.72

19.16

1.6

1.3

nmol/l

0.4

0.09

(3006504) Eosinophils/100 leukocytes in Blood

410

2822

2.01

19.01

7.3

5.9

2.7

2.8

0.75

388

2632

(3022096) Basophils/100 leukocytes in Blood

400

2731

2.00

18.96

7.5

6.0

0.7

0.19

386

2550

(3019069) Monocytes/100 leukocytes in Blood

411

2837

2.00

18.84

7.5

6.1

8.4

0.05

397

2664

(3018095) Leukocytes [#/volume] in Urine

324

2068

2.00

18.49

3.8

3.3

e6/l

114.4

107.0

0.06

277

1400

(3015235) Bicarbonate [Moles/volume] in Capillary blood

138

4.06

18.44

3.3

2.7

mmol/l

25.3

25.2

0.01

124

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

586

4627

2.24

18.26

10.8

7.2

u/l

78.9

77.5

0.35

555

4329

(3024561) Albumin [Mass/volume] in Serum or Plasma

366

2446

1.97

18.21

5.4

4.5

g/l

34.8

36.0

4.26

324

2278

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

244

1420

2.07

17.90

2.8

2.1

mg/l

3.6

3.0

2.39

216

1209

(21494814) CD8 cells/100 lymphocytes in Specimen

14.84

17.66

2.1

1.6

—

(3028026) IgM [Mass/volume] in Serum or Plasma

350

2.86

17.59

2.2

1.5

g/l

1.2

1.4

0.61

325

(3016750) Collection duration of Urine

7.97

17.50

2.5

2.1

min

519.8

486.6

0.59

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

4.80

17.46

1.8

1.7

—

(3000012) Reticulocyte production index

7.88

16.63

1.2

1.9

—

(3002030) Lymphocytes/100 leukocytes in Blood

411

2924

1.90

16.31

7.5

6.0

27.0

28.5

2.31

397

2733

(3004775) Volume in Urine collected for unspecified duration

6.60

15.46

2.4

2.2

708.4

592.9

0.50

(3013707) Erythrocyte sedimentation rate by Westergren method

563

4495

2.03

15.29

5.8

4.0

mm/h

12.8

11.3

1.68

518

4146

(3037522) Nuclear Ab [Titer] in Serum

162

857

2.14

14.97

1.5

1.3

titre

358.6

529.5

0.67

181

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

4.77

14.83

1.4

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

10.88

14.69

1.3

1.1

—

(3023368) Bacteria identified in Blood by Culture

237

1447

1.93

14.66

6.4

4.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

177

976

2.07

14.63

3.0

1.7

nmol/l

1890.0

1213.5

13.27

128

724

(40768797) Stomach Pathology biopsy report

154

808

2.14

14.50

1.4

1.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

538

4266

1.94

14.40

4.9

4.1

—

(3001604) Monocytes [#/volume] in Blood

410

3014

1.80

13.69

7.2

5.8

e9/l

0.6

3.74

388

2629

(3006315) Basophils [#/volume] in Blood

410

3025

1.79

13.42

7.2

5.8

e9/l

0.0

1.02

388

2639

(3023520) Reticulocytes [#/volume] in Blood

414

2.45

13.33

4.5

2.7

e9/l

77.3

71.8

0.75

312

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

260

1686

1.83

13.05

2.7

2.1

u/l

143.2

191.8

1.56

227

1589

(3031040) Bacteria [#/volume] in Urine by Automated count

506

3999

1.82

12.88

5.3

4.1

e6/l

3726.1

2538.7

—

(4035726)

106

501

2.30

12.81

1.5

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

6.94

12.35

3.9

2.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

4.39

12.30

1.4

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

124

3.53

12.23

1.8

1.7

—

(3018010) Neutrophils/100 leukocytes in Blood

390

2897

1.73

11.92

6.7

5.7

58.7

57.0

2.17

374

2719

(3002256) Pathology report gross observation

140

761

2.03

11.82

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1412

0.40

11.78

3.9

3.4

—

(3013115) Eosinophils [#/volume] in Blood

414

3135

1.72

11.72

7.6

6.2

e9/l

0.2

0.45

392

2777

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

670

5886

2.36

11.72

21.9

11.4

ml/min/173m2

82.3

83.9

1.18

635

4800

(3004451) EKG impression Narrative

6.47

11.59

1.2

1.3

—

(3019198) Lymphocytes [#/volume] in Blood

411

3112

1.71

11.59

7.3

5.8

e9/l

1.8

1.9

1.10

391

2771

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

129

3.39

11.52

1.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

3.98

11.21

1.4

1.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

20.40

11.16

2.1

1.6

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

371

2756

1.69

11.03

4.0

2.8

ug/l

126.5

112.5

0.55

322

2558

(3026008) Bacteria identified in Urine by Culture

261

1767

1.73

10.91

3.1

2.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

378

2.35

10.89

1.8

1.6

—

(40768795) Lymph node Pathology biopsy report

4.83

10.77

1.0

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

125

3.32

10.69

1.5

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

652

5718

2.11

10.60

8.2

4.7

mu/l

1.6

1.9

5.94

583

5260

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

4.58

10.55

1.1

1.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

102

514

2.14

10.48

2.0

2.2

g/l

0.2

1.66

487

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

5.53

10.44

1.2

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

5.38

10.16

2.0

1.4

24.8

39.1

0.85

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

104

3.48

10.11

1.2

1.5

—

(3017569) Oxygen content in Arterial blood

6.19

9.96

2.0

4.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

101

3.48

9.83

1.4

1.5

—

(3020650) Glucose [Presence] in Urine

7.49

9.73

1.1

1.3

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

7.49

9.73

2.1

1.3

3.0

6.4

—

(3048689) Calprotectin [Mass/mass] in Stool

137

789

1.90

9.67

2.7

2.4

ug/g

135.0

107.0

0.58

629

(40760888) Immunoglobulin light chains.free panel - Serum

118

3.25

9.59

3.0

4.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

219

1455

1.72

9.58

1.4

1.3

u/ml

0.6

1.6

2.68

100

415

(3015171) Extractable nuclear Ab [Units/volume] in Serum

250

2.52

9.55

1.4

1.3

—

1.8

—

(3019150) Specific gravity of Urine by Refractometry

1337

0.44

9.32

3.2

3.6

kg/l

1.0

—

174

(3026493) Urate [Moles/volume] in Serum or Plasma

222

1491

1.70

9.29

2.4

umol/l

341.2

6727.3

5.80

190

1298

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

199

2.68

9.26

1.7

1.8

ug/l

1.7

2.5

0.19

180

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

719

0.27

9.07

6.4

6.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

6.78

8.92

3.5

4.7

—

(3012516) Albumin [Mass/volume] in Urine

234

1627

1.64

8.43

3.5

3.2

mg/l

46.8

362.8

2.25

136

1014

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1404

0.48

8.41

3.1

2.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

690

6302

2.26

8.24

22.2

13.9

mmol/l

139.5

139.7

1.35

675

6124

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

166

1061

1.73

8.20

3.8

2.8

mmol/l

2.5

2.4

1.43

159

928

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

220

1517

1.64

8.15

3.2

2.9

ng/l

1114.0

1070.1

0.07

167

1271

(3023103) Potassium [Moles/volume] in Serum or Plasma

690

6324

2.21

7.80

22.5

14.0

mmol/l

3.9

4.0

0.08

674

6131

(3000570) Elastase.pancreatic [Mass/mass] in Stool

170

2.62

7.64

1.3

1.4

ug/g

276.1

302.7

0.38

106

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

102

577

1.89

7.53

4.6

4.4

u/l

221.8

240.4

1.25

543

(3003181) Sodium [Moles/volume] in Urine

3.20

7.48

1.4

1.3

mmol/l

62.1

64.9

0.13

(3013650) Neutrophils [#/volume] in Blood by Automated count

429

3500

1.53

7.38

11.5

9.1

e9/l

4.4

4.0

2.40

409

3080

(40761511) CBC panel - Blood by Automated count

705

6542

2.41

7.32

23.2

11.8

—

(3020682) Albumin/Creatinine [Ratio] in Urine

239

1718

1.58

7.32

6.1

4.0

mg/mmol

8.7

7.4

0.26

140

1056

(3009508) Creatinine [Moles/volume] in Urine

247

1789

1.57

7.32

3.5

3.1

mmol/l

7.3

7.6

0.50

185

1499

(3007164) IgA [Mass/volume] in Serum or Plasma

185

1251

1.64

7.30

1.7

1.4

g/l

2.4

0.06

130

783

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

171

1139

1.65

7.15

1.4

1.3

iu/ml

43.5

33.2

0.25

358

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

320

2.13

7.07

3.7

3.3

mmol/l

2.4

1.9

0.43

249

(3027945) Reticulocytes/100 erythrocytes in Blood

101

583

1.85

6.99

3.0

2.7

1.9

1.8

0.47

517

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

268

2.22

6.95

2.2

u/l

8107.0

2781.8

0.34

116

(3020630) Protein [Mass/volume] in Serum or Plasma

429

1.97

6.91

1.9

3.0

g/l

67.9

67.1

0.49

392

(3020961) Endomysium IgA Ab [Titer] in Serum

323

2.11

6.91

1.1

titre

—

67.6

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

719

0.37

6.84

4.2

32.9

31.7

0.19

470

(3007566) Smooth muscle Ab [Titer] in Serum

156

2.58

6.79

1.1

1.2

titre

88.0

71.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

626

5615

1.71

6.77

6.5

5.3

mmol/mol

40.9

39.3

3.18

558

5229

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

3.57

6.76

1.9

1.6

75.5

57.6

1.45

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

161

1072

1.64

6.71

1.4

1.3

u/ml

7.9

11.7

0.44

421

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

377

2.01

6.65

2.7

3.2

ng/l

94.9

76.5

0.40

333

(21494815) CD4 cells/100 lymphocytes in Specimen

4.07

6.65

3.9

2.0

—

37.0

—

(3005322) IgE [Units/volume] in Serum or Plasma

400

1.97

6.58

1.3

1.2

u/ml

245.0

226.5

0.07

365

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

159

2.53

6.54

2.9

3.9

—

2.0

—

(3007853) Bacteria identified in Skin by Aerobe culture

112

685

1.75

6.38

1.8

1.6

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

162

2.49

6.30

2.9

3.9

mg/l

43.7

83.8

—

138

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

162

2.49

6.30

2.9

3.9

mg/l

34.5

29.9

—

136

(3009343) pH of Capillary blood

336

2.02

6.23

3.7

3.3

7.4

0.31

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

134

871

1.66

6.10

1.9

—

(3004588) Protein electrophoresis panel - Serum or Plasma

361

1.97

6.06

2.1

2.6

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1030

0.51

5.77

3.1

3.6

ng/l

42.0

262.4

4.67

751

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

269

2.09

5.73

1.5

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

3.76

5.67

1.2

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

5.30

5.54

1.4

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

141

2.48

5.53

3.8

2.3

ug/min

81.1

78.8

0.02

(3026389) Candida sp identified in Specimen by Organism specific culture

2.97

5.34

2.0

1.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

5.62

5.33

1.4

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

3.28

5.20

2.9

6.2

mmol/l

7.6

7.0

0.27

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

5.32

5.05

1.2

1.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

668

6206

1.73

5.04

20.2

12.6

mg/l

18.5

22.4

2.37

601

4844

(3021788) Differential panel - Synovial fluid

105

2.63

5.02

1.7

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

944

0.53

4.90

4.2

2.5

e6/l

1.7

1.1

0.24

513

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

3.62

4.78

1.1

1.7

u/field

0.7

2.0

0.83

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

185

1362

1.48

4.78

1.7

mg/l

1.0

0.03

126

1038

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

483

4218

1.41

4.73

4.0

3.0

u/l

59.4

44.6

1.79

427

3954

(3022217) INR in Platelet poor plasma by Coagulation assay

633

0.45

4.56

14.6

21.0

inr

1.0

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

2.93

4.36

1.2

1.0

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

256

2033

1.39

4.31

3.0

3.1

u/l

31.1

32.1

0.22

227

1936

(4062490)

3.08

4.26

1.2

—

(40761535) Cells panel - Urine sediment

463

0.39

4.15

3.6

3.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

247

0.28

4.07

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

111

2.39

4.03

1.2

1.3

—

(3023419) Bacteria identified in Sputum by Culture

2.77

3.77

3.1

2.9

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

635

0.51

3.65

1.8

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

247

0.32

3.64

1.4

1.5

—

(3022621) pH of Urine by Test strip

381

0.38

3.62

2.3

2.5

—

(44813793)

2.98

3.59

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

7.84

3.56

2.0

1.0

—

(3016018) Differential panel - Cerebral spinal fluid

2.92

3.48

1.3

1.2

—

(4010399)

442

0.44

3.47

1.5

1.4

—

(3042936) Bacteria identified in Isolate by Culture

113

808

1.47

3.33

2.6

2.0

—

(40768804) Tissue Pathology biopsy report

299

2511

1.32

3.31

2.1

2.0

—

(40768443) Skin Pathology biopsy report

239

1.80

3.12

1.4

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

105

2.23

3.12

1.0

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

103

733

1.47

3.11

1.7

—

(21494755) Public health laboratory ask at order entry panel

711

0.58

3.06

1.1

1.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

7.55

3.06

1.2

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

219

1.82

3.03

3.0

2.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

876

0.62

3.02

4.2

2.7

e6/l

9.7

3.3

0.85

448

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

162

1.95

2.99

1.3

1.2

—

(3045142) Bone marrow Pathology biopsy report

2.67

2.98

1.5

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

5.04

2.73

1.3

1.2

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

492

0.53

2.72

16.6

3.6

kpa

5.8

0.02

476

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

185

0.32

2.70

1.7

2.2

g/l

2.7

3.1

—

152

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

201

0.34

2.69

1.6

2.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

168

1337

1.33

2.63

1.6

1.5

nmol/l

21.3

21.1

0.05

131

1152

(3004716) Salmonella sp identified in Stool by Organism specific culture

343

0.45

2.61

1.5

1.3

—

(3002032) Base excess in Venous blood by calculation

485

0.54

2.60

16.7

3.6

mmol/l

2.0

2.2

0.15

386

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

2.92

2.59

4.7

7.3

—

(3024869) Neuronal Ab [Presence] in Serum

7.18

2.55

1.4

1.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

122

2.00

2.53

1.3

1.5

—

(3000494) Fungus identified in Specimen by Culture

713

1.41

2.49

2.0

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

222

0.40

2.46

2.0

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

207

0.38

2.44

1.8

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

207

0.38

2.44

1.8

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

207

0.38

2.44

1.8

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

207

0.38

2.44

1.8

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

189

0.36

2.44

1.6

2.2

g/l

12.4

10.2

—

167

(3052851) Hemolysis interference index of Serum or Plasma

162

0.30

2.42

1.6

3.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

251

0.39

2.42

1.2

1.8

—

(3024354) Oxygen [Partial pressure] in Venous blood

410

0.52

2.41

17.2

3.0

kpa

4.7

4.6

0.05

394

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

5.03

2.40

1.0

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

111

2.01

2.37

3.9

3.6

umol/l

39.9

32.6

0.73

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

4.15

2.36

1.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

316

0.46

2.36

22.5

3.5

g/l

128.7

128.6

0.00

311

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

688

6620

1.51

2.35

14.6

9.8

u/l

27.7

26.1

1.39

655

6396

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

154

0.32

2.30

1.8

2.1

g/l

0.0

—

146

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

3.91

2.25

1.0

134.6

128.9

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

2.12

2.24

1.1

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

732

1.37

2.15

1.8

1.6

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

130

1.87

2.14

1.3

1.2

e6/l

16.2

6.1

0.34

103

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

130

1.87

2.14

1.3

e6/l

10.9

108.0

1.28

106

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

130

1.87

2.14

1.1

1.2

mmol/l

4.1

3.7

0.69

120

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

478

1.44

2.05

1.3

1.2

iu/ml

108.0

142.1

0.35

202

(3048929) Epstein Barr virus Ab [Presence] in Serum

201

1.67

2.02

1.2

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

2.65

2.01

1.0

2.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

112

1.90

1.98

1.4

u/ml

91.0

106.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

268

0.48

1.96

7.3

10.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

2.38

1.95

1.1

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

4.57

1.94

3.8

1.4

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

3.77

1.94

4.3

1.1

nmol/l

284.2

114.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.77

1.94

1.2

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

3.77

1.94

1.2

1.1

65.3

104.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

2.59

1.92

1.1

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

174

0.40

1.92

2.1

1.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

162

1337

1.27

1.91

4.9

4.5

ug/l

1.7

2.3

1.54

136

1202

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

143

1.77

1.91

4.2

2.3

u/ml

0.4

0.24

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

317

0.53

1.91

2.0

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

156

1871

0.79

1.87

2.4

2.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

627

5985

1.30

1.86

5.3

4.3

mmol/l

6.0

5.9

0.95

538

5473

(42529406) Shigella sp [Presence] in Stool by Culture

198

0.45

1.86

1.7

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

450

0.61

1.85

1.7

2.4

ug/l

6.8

6.5

0.06

401

(36660697) Celiac disease serology panel - Serum

486

0.62

1.84

1.3

1.2

—

(3005033) Fetal Nuchal fold Thickness US

168

0.41

1.80

1.9

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

168

0.41

1.80

1.9

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

2.36

1.78

1.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

155

1286

1.26

1.75

1.6

1.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

194

0.46

1.74

1.7

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

195

0.45

1.74

1.7

1.2

—

(3000991) Gas panel - Venous blood

418

0.61

1.73

13.7

8.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

2.68

1.72

2.9

4.2

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

242

0.49

1.72

27.5

2.9

0.7

0.13

234

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

179

1.65

1.72

2.0

1.8

iu/l

2.4

5.5

2.61

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

2.31

1.71

1.4

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.31

1.71

1.4

1.3

—

(3004809) Band form neutrophils/100 leukocytes in Blood

1.95

1.65

2.8

3.1

1.4

0.9

0.39

(3003327) Ova and parasites identified in Stool by Light microscopy

205

1.59

1.65

1.8

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

604

1.34

1.65

1.7

1.8

—

(3007461) Platelets [#/volume] in Blood

714

6976

1.55

1.64

29.7

18.7

e9/l

261.2

254.5

1.51

699

6806

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

158

1.67

1.64

1.4

1.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1082

0.76

1.63

4.1

23.2

21.3

0.63

492

(3024731) MCV [Entitic volume]

714

6978

1.54

1.62

29.6

18.6

91.0

90.7

0.72

701

6879

(3035941) MCH [Entitic mass]

714

6978

1.54

1.62

29.6

18.6

30.1

30.2

0.78

701

6877

(3026361) Erythrocytes [#/volume] in Blood

714

6979

1.54

1.60

29.7

18.6

e12/l

4.5

0.20

699

6793

(3019225) pH of Specimen

516

0.66

1.60

5.7

3.7

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

433

0.63

1.60

1.4

—

(3010813) Leukocytes [#/volume] in Blood

714

6980

1.53

1.59

29.9

18.7

e9/l

7.0

6.6

3.74

699

6788

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

152

1.67

1.58

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.71

1.58

1.0

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

128

1052

1.26

1.57

1.7

1.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1.87

1.57

1.2

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

537

0.67

1.57

4.9

2.5

u/l

27.4

41.3

0.93

455

(3011288) Drugs identified in Urine by Screen method

176

1.61

1.57

3.0

2.3

—

(3000963) Hemoglobin [Mass/volume] in Blood

714

6983

1.52

1.55

30.2

18.7

g/l

134.4

135.4

0.99

701

6881

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

147

1.65

1.49

1.5

1.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

597

1.32

1.48

1.7

1.8

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

240

0.53

1.46

2.3

3.6

50.8

49.2

0.08

235

(3027273) Bicarbonate [Moles/volume] in Venous blood

251

0.55

1.43

2.9

3.4

mmol/l

24.1

25.1

0.48

244

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

103

1.77

1.42

1.1

iu/ml

11.3

61.5

—

(40768441) Liver Pathology biopsy report

2.26

1.40

1.3

1.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

775

1.27

1.38

1.9

1.8

1.6

1.4

0.64

693

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

209

0.52

1.36

2.0

1.8

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

561

1.31

1.35

3.8

4.3

ug/l

6.3

28.4

0.90

464

(3022313) Gas panel - Capillary blood

246

0.56

1.35

5.1

3.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

1.34

0.0

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

710

0.74

1.32

1.6

1.4

—

(3049717) Cytology report of Urine Cyto stain

185

1.53

1.31

2.5

2.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

161

1.57

1.30

2.3

2.0

mg/l

4.6

11.4

5.42

147

(3000330) Specific gravity of Urine by Test strip

280

0.60

1.29

1.8

3.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.37

1.29

1.3

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

2.01

1.28

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

614

5911

1.22

1.27

4.3

3.7

mmol/l

1.4

1.3

3.75

527

5449

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

141

1202

1.21

1.25

1.6

1.4

—

(3045424) Erythrocytes [Presence] in Urine

108

1.68

1.23

1.1

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

116

1.65

1.22

1.5

1.2

u/ml

286.9

240.2

0.30

(3000492) Spirometry study

606

1.28

1.22

1.4

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.64

1.21

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.64

1.21

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.64

1.21

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.64

1.21

1.2

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

148

1272

1.20

1.21

2.1

1.9

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1.76

1.19

2.1

1.7

—

(3006653) Thiamine [Moles/volume] in Blood

2.32

1.19

1.2

1.3

nmol/l

113.2

150.5

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

2.32

1.19

1.2

2.5

99.5

96.3

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

2.35

1.12

6.0

2.8

u/ml

416.1

949.2

—

(3012441) Differential panel - Pleural fluid

1.97

1.11

1.3

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

218

1.44

1.11

1.8

2.1

g/l

1.5

0.00

193

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

2.20

1.08

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

2.20

1.08

1.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

764

1.23

1.07

2.4

1.9

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

2.13

1.05

1.1

1.8

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

2.07

1.03

1.0

1.1

—

(3024928) Oxygen saturation in Venous blood

107

0.46

1.01

63.6

3.8

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

123

1.56

1.00

1.3

1.2

—

(3037756) Immunofixation for Serum or Plasma

116

1.57

0.97

1.6

1.7

—

(4027681)

1.95

0.97

2.0

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

216

1.41

0.97

1.2

1.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

183

1.44

0.95

2.0

1.9

92.0

91.9

0.01

171

(3039162) Centromere protein B Ab [Units/volume] in Serum

1.66

0.95

1.2

1.3

—

25.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1.77

0.94

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

221

0.63

0.94

2.5

1.9

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

1.79

0.94

1.0

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

1.74

0.92

2.1

2.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

444

4216

1.13

0.91

3.3

3.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

468

1.26

0.89

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

127

0.55

0.89

1.7

2.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

161

1.44

0.87

1.9

2.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

274

0.69

0.85

2.5

1.8

mg/l

4.0

3.1

0.24

193

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

1.68

0.85

1.1

g/l

1.4

0.22

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.88

0.82

1.0

1.3

—

(40768793) Breast Pathology biopsy report

181

1.39

0.81

1.4

1.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

0.79

0.0

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

208

1.36

0.78

2.3

1.8

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

631

6155

1.16

0.78

5.0

4.2

mmol/l

4.6

4.7

2.16

543

5718

(3003396) Base excess in Arterial blood by calculation

580

0.80

0.77

6.1

7.4

mmol/l

2.0

1.2

0.63

463

(3020891) Body temperature

209

1.35

0.76

3.5

4.0

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

387

1.26

0.76

1.5

1.3

au/ml

53.3

31.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.09

0.74

1.2

1.4

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

2.09

0.74

1.0

2.5

u/l

170.6

218.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

843

1.17

0.74

1.9

30.9

29.5

2.04

819

(3047189) Immunofixation for 24 hour Urine

2.01

0.72

1.2

1.8

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

1.63

0.72

3.5

4.8

u/ml

91.8

105.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

126

1.44

0.71

1.6

1.7

—

(3035880) pH of Pleural fluid

1.93

0.70

1.6

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

628

6134

1.15

0.70

4.9

4.1

mmol/l

1.4

1.5

3.00

539

5673

(3003434) Protein [Mass/volume] in Pleural fluid

1.56

0.70

1.1

1.4

g/l

33.1

33.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.86

0.68

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

841

1.16

0.67

2.5

2.0

—

(3028707) Methadone [Presence] in Urine by Screen method

119

1.44

0.67

2.2

2.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

0.53

0.67

1.4

u/l

13.6

25.9

—

(4094501)

162

1.37

0.67

1.2

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

730

1.17

0.65

2.0

1.7

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

131

0.61

0.64

2.3

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

101

0.59

0.62

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

1.64

0.62

2.1

1.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

186

0.69

0.60

1.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

0.00

0.60

0.0

1.8

—

1276.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.00

0.60

0.0

3.7

—

(3033658) Prothrombin time (PT) actual/Normal

134

1475

0.89

0.59

4.3

3.5

94.9

93.3

0.29

128

1433

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.59

0.0

1.0

—

28.8

—

(40768806) Pleura Pathology biopsy report

1.51

0.58

1.1

1.7

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

114

0.61

0.58

1.1

—

11.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1.44

0.57

1.0

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

655

1.16

0.56

2.6

2.5

umol/l

5.4

7.7

1.42

565

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

172

0.69

0.56

1.2

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

148

0.67

0.55

1.5

4.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

122

0.65

0.55

2.5

3.6

mg/l

39.2

26.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.58

0.54

1.0

1.2

—

(3015183) Erythrocyte sedimentation rate

1.54

0.53

1.0

1.2

—

(4281824)

1.43

0.52

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

191

0.73

0.51

1.2

—

(3019060) Gas panel - Arterial blood

334

1.21

0.51

2.5

4.3

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

1.50

0.50

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

108

0.64

0.49

1.3

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

177

0.73

0.47

1.5

1.3

—

(3003694) ABO and Rh group [Type] in Blood

164

1762

0.91

0.47

2.0

1.5

—

(3016879) Cocaine [Presence] in Urine

246

1.23

0.46

2.2

1.7

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.39

0.46

1.4

1.2

u/ml

1.0

4.8

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.57

0.42

1.2

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

636

6263

1.11

0.42

5.2

4.6

mmol/l

2.7

2.8

1.30

544

5775

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

1.52

0.41

1.2

1.3

—

28.3

—

(3003129) Base excess in Capillary blood by calculation

0.00

0.41

0.0

1.1

—

1.9

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

4.7

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.00

0.41

0.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.41

0.0

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.41

0.0

1.3

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

1.9

—

2.6

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

141

1.28

0.40

1.2

—

7.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.47

0.40

1.0

1.1

—

(3036489) Thrombin time

214

1.22

0.40

2.0

1.8

22.4

21.0

0.39

193

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

105

0.66

0.39

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.43

0.39

1.4

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

106

1.33

0.39

1.3

1.2

—

(3044007) Cell count panel - Peritoneal fluid

0.00

0.39

0.0

1.6

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.00

0.39

0.0

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

1.37

0.38

1.2

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

344

0.84

0.38

1.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

336

1.17

0.38

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

365

1.16

0.37

1.7

1.9

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.35

0.37

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

1.36

0.36

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.66

0.36

1.2

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

0.65

0.36

1.4

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.43

0.35

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.43

0.35

1.3

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

283

1.17

0.35

2.2

2.4

e6/l

0.4

0.2

0.33

273

(3014148) Varicella zoster virus Ab [Titer] in Serum

1.37

0.34

1.5

1.2

—

(1002224) Polysomnography panel

286

0.83

0.34

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1.32

0.34

1.3

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.34

0.34

1.5

1.1

—

(40768800) Prostate Pathology biopsy report

1.36

0.32

1.4

1.1

—

(40758558) Short blood count panel - Blood

144

1526

0.93

0.31

5.4

6.6

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

202

1.19

0.31

1.5

3.0

u/ml

24.9

1062.4

0.86

172

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

193

1.20

0.31

2.1

1.6

—

0.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

218

0.82

0.30

1.3

miu/ml

284.8

242.8

—

111

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

377

0.87

0.30

1.4

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

396

0.88

0.28

1.7

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.30

0.28

1.3

1.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

1.23

0.27

11.1

6.2

mg/l

13.3

11.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

187

1.18

0.27

1.2

1.6

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

1.24

0.25

2.6

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

221

2287

0.95

0.23

1.7

1.9

pmol/l

97.5

96.7

0.08

109

1166

(4306422)

1.25

0.22

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

189

0.84

0.22

2.0

1.6

—

(3000764) Benzodiazepines [Presence] in Urine

267

1.13

0.22

2.2

1.7

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1.19

0.21

1.4

1.5

g/l

0.8

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.00

0.21

0.0

6.8

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.00

0.21

0.0

6.8

—

(3000285) Sodium [Moles/volume] in Blood

0.00

0.21

0.0

1.1

—

(4015189)

0.00

0.21

0.0

2.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.00

0.21

0.0

7.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.00

0.21

0.0

1.4

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

0.00

0.21

0.0

3.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

291

2835

1.04

0.21

4.9

3.9

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.21

0.0

2.7

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.21

0.0

5.3

—

(3034988) Calcium [Moles/volume] in Capillary blood

0.00

0.21

0.0

2.3

—

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.16

0.21

1.0

1.1

—

(3027008) Opiates [Presence] in Urine

268

1.12

0.21

2.2

1.7

—

(3028300) Cannabinoids [Presence] in Urine

268

1.12

0.21

2.2

1.7

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.21

0.0

1.0

—

(4133840)

0.00

0.21

0.0

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.00

0.20

0.0

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

112

0.80

0.20

1.3

1.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

787

0.93

0.20

3.9

2.8

ug/l

0.7

0.04

480

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.20

0.19

1.0

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.20

0.19

1.0

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.20

0.19

1.0

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.18

0.19

1.0

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.18

0.19

1.0

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.18

0.19

1.0

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

466

0.92

0.18

2.3

2.4

ml/min/173m2

50.3

69.5

2.77

194

(3002523) Influenza virus A Ag [Presence] in Specimen

121

0.82

0.18

1.8

1.1

—

(4268621)

0.76

0.17

3.0

2.3

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

0.75

0.15

1.8

1.9

—

1744.0

—

(3009542) Hematocrit [Volume Fraction] of Blood

584

5790

1.04

0.15

13.3

13.5

40.8

40.1

1.39

280

4342

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1.13

0.15

1.4

1.1

—

(3027944) Amphetamines [Presence] in Urine

266

1.09

0.14

2.1

1.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

284

0.91

0.13

2.2

2.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

133

1.13

0.12

1.1

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

1.09

0.09

3.0

2.1

—

(3017732) Neutrophils [#/volume] in Blood

429

1.05

0.09

2.3

2.8

e9/l

3.8

4.2

0.74

338

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

113

0.88

0.08

1.0

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

113

0.88

0.08

1.0

1.4

—

(3023410) Appearance of Cerebral spinal fluid

0.81

0.08

1.6

1.3

—

(44806118)

0.78

0.08

1.6

—

(44790049)

0.78

0.08

1.6

—

(44790048)

0.78

0.08

1.6

—

(44790047)

0.78

0.08

1.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.83

0.07

1.0

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

461

1.04

0.07

2.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

121

0.91

0.06

1.7

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

415

1.04

0.05

1.1

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

159

1.07

0.05

1.4

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

137

0.95

0.01

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

104

0.96

0.00

1.1

1.6

—

(3008898) HLA-B27 [Presence]

267

1.01

0.00

1.1

—

(3045414) Leukocytes [Presence] in Urine

259

1.00

0.00

1.3

1.7

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

0.95

0.00

1.0

1.1

—

0.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.0

7.7

—

(3044941) Cell count panel - Synovial fluid

0.97

0.00

1.1

1.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

0.97

0.00

1.0

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.4

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.00

0.0

1.4

—

37.8

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

0.00

0.0

2.4

—

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.0

1.4

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.93

0.00

3.0

1.9

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

0.0

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.00

0.0

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.00

0.0

6.4

—

(3014891) Appearance of Pleural fluid

0.00

0.0

1.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.1

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

0.00

0.0

1.0

—

73.5

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

0.0

1.0

—

(3044927) Protein electrophoresis panel - Urine

1.02

0.00

1.2

1.1

—

(3013762) Body weight Measured

0.00

0.0

1.7

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

1.00

0.00

1.0

1.1

nmol/l

—

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.0

1.6

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

8.7

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

0.0

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.94

0.00

1.2

2.9

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.86

0.00

1.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_ENDODISNAS and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_ENDODISNAS	1.723 [1.5, 1.98]	< 0.001
Birth year	0.997 [0.99, 1.01]	0.433

During the follow-up period (1.1.1998 — 31.12.2019), 435 out of 2137 females with E4_ENDODISNAS died.

Males

Parameter	HR [95% CI]	p-value
E4_ENDODISNAS	2.082 [1.77, 2.45]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.076

During the follow-up period (1.1.1998 — 31.12.2019), 361 out of 1294 males with E4_ENDODISNAS died.

Mortality risk

Mortality risk for people of age

years, who have E4_ENDODISNAS.

N-year risk	Females	Males
1	0.181%	0.487%
5	0.917%	2.933%
10	2.625%	6.936%
15	5.304%	12.736%
20	8.779%	21.356%

Relationships between endpoints

↥

Index endpoint: E4_ENDODISNAS – Endocrine disorders, other/unspecified

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Endocrine disorders, other/unspecified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints